These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6239841)

  • 21. [The immunodepressant effect of a bacterial extract in skin allotransplantation in mice].
    Kirpatovskiĭ ID; Stanislavskiĭ ES
    Eksp Khir Anesteziol; 1971; 16(1):51-3. PubMed ID: 4944578
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients.
    Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Alwayn IP; Weimar W; Hoogduijn MJ
    Transplantation; 2009 Mar; 87(6):896-906. PubMed ID: 19300194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological concepts relating to organ transplantation].
    Dei Poli G; Massa G; Rosso PA; Dei Poli N
    Minerva Chir; 1980 Jun; 35(11):829-78. PubMed ID: 6450338
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of immunosuppressive factors expressed in serum by rat tolerogenic liver transplantation.
    Nakano T; Kawamoto S; Lai CY; Hsu LW; Lin YC; Sasaki T; Aki T; Shigeta S; Goto T; Ohmori N; Sato S; Goto S; Ono K; Chen CL
    Transplant Proc; 2005; 37(1):80-1. PubMed ID: 15808554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLR and skin graft studies in xenogeneic iso-, allo-, and xeno-combinations using HLA-DP and -DQ transgenic mice.
    Hagihara M; Shimura T; Tsuchida F; Takebe K; Munkhbat B; Tsuji K
    Transplant Proc; 1994 Apr; 26(2):967-8. PubMed ID: 8171718
    [No Abstract]   [Full Text] [Related]  

  • 27. The stimulating and suppressive properties of anti-lymphocyte serum (ALS) on lymphocyte transformation in vitro.
    Eijsvoogel VP; Schellekens PT; van Loghem JJ; Du Bois MJ
    Transplant Proc; 1969 Mar; 1(1):408-12. PubMed ID: 4944251
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of the guinea pig's middle ear cell-mediated response using the mixed lymphocyte response (MLR).
    Cormier R; Poliquin JF; Goyette B; Shariatmadar A
    J Otolaryngol; 1987 Mar; 16(2):67-70. PubMed ID: 2955130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin allograft survivals in relation to HL-A incompatibilities and response in MLC.
    Sasportes M; Lebrun A; Rapaport FT; Dausset J
    Transplant Proc; 1973 Mar; 5(1):353-8. PubMed ID: 4266660
    [No Abstract]   [Full Text] [Related]  

  • 30. Cellular and antigenic requirements for production of mixed leukocyte reaction suppressor factor.
    Dennison DK; Rich SS; Rich RR
    J Immunol; 1981 Nov; 127(5):2176-82. PubMed ID: 6457865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of FK 506 or rapamycin.
    Iwata H; Nagano T; Toyo-oka K; Hirose H; Hamaoka T; Fujiwara H
    Transplant Proc; 1994 Apr; 26(2):851-4. PubMed ID: 7513476
    [No Abstract]   [Full Text] [Related]  

  • 32. Induction of tolerance in a rat model of laryngeal transplantation.
    Akst LM; Siemionow M; Dan O; Izycki D; Strome M
    Transplantation; 2003 Dec; 76(12):1763-70. PubMed ID: 14688529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large scale production of rabbit-derived anti-idiotypic antibodies: a new tool in immunosuppressive therapy?
    Greger B; Tent S
    Transplant Proc; 1996 Dec; 28(6):3205-7. PubMed ID: 8962242
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunosuppressive effect of stepronin (TS-5010680) in mice.
    de Giorgi L; Arrigoni-Martelli E; Matossian-Rogers A
    Transplant Proc; 1994 Dec; 26(6):3513-6. PubMed ID: 7998255
    [No Abstract]   [Full Text] [Related]  

  • 35. [Extra-corporeal irradiation of the blood and thoracic duct lymph as anti-leukemic and immunosuppressive therapy].
    Okuyama S; Ito Y; Kanno I
    Saishin Igaku; 1971 Oct; 26(10):1977-85. PubMed ID: 4942702
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolongation of skin graft survival by exogenous ubiquitin.
    Earle SA; El-Haddad A; Patel MB; Ruiz P; Pham SM; Majetschak M
    Transplantation; 2006 Dec; 82(11):1544-6. PubMed ID: 17164731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vitro system for the determination of individualized immunosuppression.
    Linnebacher M; Blauscha C; Wacke R; Kottek T; Stein Sv; Kiefel V; Hakenberg OW; Klar E
    Transplant Proc; 2008 May; 40(4):918-20. PubMed ID: 18555078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppression following excision of burn eschar and syngeneic grafting in major thermal trauma.
    Jacobson BK; Baker CC
    Yale J Biol Med; 1984; 57(5):797-808. PubMed ID: 6240833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xenogeneic iso-, allo-, and xeno-MLR and CML assay using HLA-DP and -DQ transgenic mice.
    Hagihara M; Shimura T; Tsuchida F; Takebe K; Munkhbat B; Tsuji K
    Transplant Proc; 1994 Jun; 26(3):1319-20. PubMed ID: 8029923
    [No Abstract]   [Full Text] [Related]  

  • 40. Purified hepatic parenchymal cells are nonimmunogenic in vitro.
    Karrer FM; Gill R; Ostrowska A; Bolwerk A; Reitz B; Stegall M; Schroter G; Kam I; Lafferty KJ
    Transplant Proc; 1995 Feb; 27(1):625-7. PubMed ID: 7879124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.